INmune Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $14 | $28 |
Gross Profit | 14 | 28 | ||
EBITDA | -12,286 | -9,865 | -11,017 | -8,408 |
EBIT | -19,730 | -22,034 | -16,787 | |
Net Income | -12,093 | -9,746 | -11,025 | -8,408 |
Net Change In Cash | 0 | 0 | 14 | 28 |
Free Cash Flow | -6,986 | -7,886 | -7,476 | -3,401 |
Cash | 33,552 | 31,069 | 26,002 | 35,848 |
Basic Shares | 20,185 | 19,307 | 18,026 | 17,950 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $155 | $374 | $181 | $10 |
Gross Profit | 155 | 374 | 181 | 10 |
EBITDA | -29,741 | -27,299 | -30,340 | -12,227 |
EBIT | -59,482 | -25,951 | -29,153 | -12,227 |
Net Income | -30,008 | -28,647 | -30,340 | -12,099 |
Net Change In Cash | 155 | 374 | 181 | 10 |
Cost of Revenue | -21,957 | 52,843 | 14,971 | |
Free Cash Flow | -11,980 | -22,686 | -43,504 | -8,943 |
Cash | 35,848 | 52,153 | 74,810 | 21,966 |
Basic Shares | 17,980 | 17,927 | 16,130 | 11,988 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.60 |
2024-06-30 | -$0.50 |
2024-03-31 | -$0.61 |
2023-12-31 | -$0.47 |
